| Drug Type Prophylactic vaccine, mRNA vaccine | 
| Synonyms N332-GT5 gp151 mRNA | 
| Target- | 
| Action stimulants | 
| Mechanism Immunostimulants | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| HIV Infections | Phase 1 | South Africa  | 09 Sep 2025 | |
| HIV Infections | Phase 1 | South Africa  | 09 Sep 2025 | 





